Safety and effectiveness of the sodium‐glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus

Abstract Background Bexagliflozin is a sodium‐glucose cotransporter 2 (SGLT2) inhibitor. A pilot study has shown that bexagliflozin can decrease dependence on exogenous insulin in cats with diabetes mellitus (DM). Objective To evaluate the safety and effectiveness of bexagliflozin as a monotherapy f...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michael J. Hadd, Stephen E. Bienhoff, Susan E. Little, Samuel Geller, Jennifer Ogne‐Stevenson, Thomas J. Dupree, J. Catharine Scott‐Moncrieff
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2023-05-01
coleção:	Journal of Veterinary Internal Medicine
Assuntos:	feline field study fructosamine half‐life hyperglycemia SGLT2
Acesso em linha:	https://doi.org/10.1111/jvim.16730
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!